Skip to main content

Erectile Dysfunction and Cardiovascular Risk Factors

  • Chapter

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

Erectile dysfunction (ED), the consistent inability of a man to achieve an erection satisfactory for sexual activity, has been estimated to afflict, to some degree, 52% of male adults between the ages of 40 and 70 yr in the United States (1).Millions of men in the United States suffer with ED. Although there are numerous causes of ED (vascular, psychogenic, neurologic, endocrine, structural, traumatic, and drug-related) in men over age 50 yr, the most common cause is thought to be vascular (2–4). This chapter reviews the connection between ED and vascular disease and the connection between ED and risk factors for atherosclerosis.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    PubMed  CAS  Google Scholar 

  2. Morley JE, Kaiser FE. Impotence in elderly men. Drugs Aging 1992; 2: 330–344.

    Article  PubMed  CAS  Google Scholar 

  3. Sullivan ME, Keoghane SR, Miller MAW. Vascular risk factors and erectile dysfunction. BJU Int 2001; 87: 838–845.

    Article  PubMed  CAS  Google Scholar 

  4. Bortolotti A, Parazzini F, Colli E, et al. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323–334.

    Article  PubMed  CAS  Google Scholar 

  5. Jarow J, Kloner RA, Holmes AM. Viagra M. Evans and Company, Inc. New York, 1998, pp. 1–150.

    Google Scholar 

  6. Burnett AL. Nitric oxide in the penis: physiology and pathology. J Urol 1997; 157: 320–324.

    Article  PubMed  CAS  Google Scholar 

  7. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 8422: 181–184.

    Article  Google Scholar 

  8. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prey Med 2000; 30: 328–338.

    Article  CAS  Google Scholar 

  9. Bulpitt CJ, Dollery CT, Carne S. Change in symptom of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38: 121–128.

    Article  PubMed  CAS  Google Scholar 

  10. Burchardt M, Burchardt T, Baer L, et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188–1191.

    Article  PubMed  CAS  Google Scholar 

  11. Williams GH, Croog SH, Levine S, et al. Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide. J Hypertens 1987; 5 (Suppl 1): S29 - S35.

    CAS  Google Scholar 

  12. Jensen J, Lendorf A, Stimpel H, et al. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 1999; 12: 271–275.

    Article  PubMed  CAS  Google Scholar 

  13. Grimm RH, Grandits GA, Priueas RJ, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women in the Treatment of Mild Hypertension Study. (THOMS) Hypertension 1997; 29: 8–14.

    CAS  Google Scholar 

  14. Wassertheil-Smoller S, Blaufox MD, Oberman A, et al., for the TAIM Research Group. Effects of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med 1991; 114: 613–620.

    PubMed  CAS  Google Scholar 

  15. Fogari R, Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001; 14: 27–31.

    Article  PubMed  CAS  Google Scholar 

  16. Wei M, Macera CA, Davis DR, et al. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994; 140: 930–937.

    PubMed  CAS  Google Scholar 

  17. Rosen RC, Weiner DN. Cardiovascular disease and sleep-related erections. J Psychosom Res 1997; 42: 515–516.

    Article  Google Scholar 

  18. Rizvi K, Hampson JP, Harvey JN. Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Fam Pract 2002; 19: 95–98.

    Article  PubMed  Google Scholar 

  19. Derby CA, Mohr BA, Goldstein I, et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–306.

    Article  PubMed  CAS  Google Scholar 

  20. McVary KT, Carrier S, Wessells H, the Subcommittee on smoking and erectile dysfunction, Socioeconomic Committee, Sexual Medicine Society of North America. Smoking and erectile dysfunction: evidence-based analysis. J Urol 2001; 166: 1624–1632.

    Article  PubMed  CAS  Google Scholar 

  21. Jeremy JY, Mikhallidis DP, Thompson CS, et al. The effect of cigarette smoke and diabetes mellitus on muscarinic stimulation of prostacyclin synthesis by the rat penis. Diabetes Res 1986; 3: 467–469.

    PubMed  CAS  Google Scholar 

  22. Shabsigh R, Fishman IJ, Schum C, et al. Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology 1991; 38: 227–231.

    Article  PubMed  CAS  Google Scholar 

  23. Rosen MP, Greenfield AJ, Walker TG, et al. Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J Urol 1991; 145: 759–763.

    PubMed  CAS  Google Scholar 

  24. Mannino DM, Klevens RM, Flanders WD. Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol 1994; 140: 1003–1008.

    PubMed  CAS  Google Scholar 

  25. Ledda A. Cigarette smoking, hypertension and erectile dysfunction. Curr Med Res Opin 2000; 16 (Suppl 1): S13 - S16.

    Article  PubMed  Google Scholar 

  26. Juenemann K-P, Lue TF, Luo J-A, et al. The effect of cigarette smoking on penile erection. J Urol 1987; 138: 438–441.

    PubMed  CAS  Google Scholar 

  27. Jacobs MC, Lenders JW, Kapma JA, et al. Effect of chronic smoking on endothelium-dependent vascular relaxation in humans. Clin Sci 1993; 85: 51–55.

    PubMed  CAS  Google Scholar 

  28. Levine LA, Gerber GS. Acute vasospasm of penile arteries in response to cigarette smoking. Urology 1990; 36: 99–100.

    Article  PubMed  CAS  Google Scholar 

  29. Mersdorf A, Goldsmith PC, Diederichs W, et al. Ultrastructural changes in impotent penile tissue: a comparison of 65 patients. J Urol 1991; 145: 749–758.

    PubMed  CAS  Google Scholar 

  30. Guay AT, Perez JB, Heatly GJ. Cessation of smoking rapidly decreases erectile dysfunction. Endocrine Pract 1998; 4: 23.

    CAS  Google Scholar 

  31. Klein R, Klein BEK, Lee ICE, et al. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996; 19: 135–141.

    Article  PubMed  CAS  Google Scholar 

  32. De-Tejada IS, Goldstein I, Azadzoi K, et al. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025–1030.

    Article  Google Scholar 

  33. Guay AT. Sexual dysfunction in the diabetic patients. Int J Impot Res 2001; 13 (Suppl 5): S47 - S50.

    Article  PubMed  Google Scholar 

  34. Greenstein A, Chen J, Miller H, et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123–126.

    Article  PubMed  CAS  Google Scholar 

  35. Pritzker MR. The penile stress test: a window to the hearts of man? 72nd Scientific Sessions of the American Heart Association, November 7–10, 1999; Atlanta, Georgia. Abstract 104–561.

    Google Scholar 

  36. O’Kane PD, Jackson G. Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract 2001; 55: 219–220.

    PubMed  Google Scholar 

  37. Kirby M, Jackson G, Betteridge J, et al. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001; 155: 614–618.

    Google Scholar 

  38. Kloner RA, Mullin SH, Shook T, et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol 2003; 170: S46–550.

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Kloner, R.A. (2004). Erectile Dysfunction and Cardiovascular Risk Factors. In: Kloner, R.A. (eds) Heart Disease and Erectile Dysfunction. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-748-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-748-2_3

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9849-3

  • Online ISBN: 978-1-59259-748-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics